Advertisement

Topics

Athersys Company Profile

05:24 EDT 23rd September 2017 | BioPortfolio

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.
As represented by its name, (Athersys - derived from advanced therapeutic systems), the Company is committed to developing novel therapeutic products that deliver substantial improvements over existing therapies through the application and utilization of its advanced, proprietary technology platforms.

Through internal development and acquisition of key technologies, Athersys has established a unique blend of competencies in areas such as molecular biology, cell biology, genomics, protein biochemistry, medicinal chemistry, and pharmacology. The Company has fully integrated pre-clinical drug discovery and development capabilities, and is focused on advancing a portfolio of therapeutic development programs into the clinic.

Location

3201 Carnegie Avenue
Cleveland
Ohio
44115-2634
United States of America

Contact

Phone: 216-431-9900
Fax: 216-361-9495
Email: jobs@athersys.com., ir@athersys.com


News Articles [18 Associated News Articles listed on BioPortfolio]

Athersys, Inc. (ATHX) Upgraded to Buy by Zacks Investment Research

Zacks Investment Research currently has $1.75 price target on the biopharmaceutical company's stock. According to Zacks, "Athersys is a biopharmaceutical company engaged in the discovery and devel...

Athersys Reports First Quarter 2017 Results

Company announces Fast Track Designation by FDA for Stroke Program and other progress  Management to host conference call at 4:30pm EDT todayCLEVELAND, May 09, 2017 (GLOBE NEWSWIRE) -- Athersys, ...

Regulatory Alignment Reinforces Bullish Case For Athersys

Upcoming Short- And Long-Term Catalysts For Athersys

Athersys's Cardiovascular Health Program Is Ambitious and Well-Calculated

Athersys And Aurinia Target Human And Animal Health

Athersys Is Poised To Disrupt The Ischemic Stroke Market

Athersys' (ATHX) CEO Gil Van Bokkelen on Q2 2017 Results - Earnings Call Transcript

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Athersys Incorporated

Athersys is a biotechnology company engaged in the research and development of products for the treatment and diagnosis of genetic and immunologic disorders. The company has a core expertise in the f...

Athersys

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.As represented by its name, (Ather...

Athersys, Inc.

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company ...

More Information about "Athersys" on BioPortfolio

We have published hundreds of Athersys news stories on BioPortfolio along with dozens of Athersys Clinical Trials and PubMed Articles about Athersys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athersys Companies in our database. You can also find out about relevant Athersys Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record